Home The Word Brain My Amedeo FAQ Privacy About   


Chinese Coaching

Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.


  Multiple Sclerosis

  Free Subscription


19.01.2026

1 J Clin Invest
2 J Neurol
1 J Neurol Neurosurg Psychiatry
2 Mult Scler


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    J Clin Invest

  1. DONALDSON A, Druker MR, Monaco MC, Stack EH, et al
    Broad-spectrum antiviral brincidofovir inhibits Epstein-Barr virus and related gammaherpesvirus in human and nonhuman primate cells.
    J Clin Invest. 2025 Nov 25:e195764. doi: 10.1172/JCI195764.
    PubMed         Abstract available


    J Neurol

  2. GYGER N, Monschein T, Filser M, Batge S, et al
    Cognitive training, exercise training or combined training? A comparative effectiveness research study on subjective and objective cognitive outcomes in multiple sclerosis.
    J Neurol. 2026;273:82.
    PubMed         Abstract available

  3. GRECO G, Della Porta G, Masi F, Redemagni C, et al
    Two-year OCT follow-up in multiple sclerosis patients on Ofatumumab shows retinal preservation over non-antiCD20 treatments.
    J Neurol. 2026;273:77.
    PubMed         Abstract available


    J Neurol Neurosurg Psychiatry

  4. KREFT KL, Mekkes NJ, Uzochukwu E, Loveless S, et al
    Genetic subtypes associated with multiple sclerosis severity and response to treatment.
    J Neurol Neurosurg Psychiatry. 2026 Jan 16:jnnp-2025-337337.
    PubMed         Abstract available


    Mult Scler

  5. VAN DER WALT A
    Multiple sclerosis controversies: Detecting progressing events in MS clinics in real-time is possible-commentary.
    Mult Scler. 2026 Jan 14:13524585251409579. doi: 10.1177/13524585251409579.
    PubMed        

  6. NESBITT C, Van Der Walt A, Butzkueven H, Rath L, et al
    Violence and multiple sclerosis: Towards an evidence-informed call to action in neurology.
    Mult Scler. 2026 Jan 13:13524585251409580. doi: 10.1177/13524585251409580.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.